CRC 656 Z05 - Organic Chemistry, Radiopharmaceutical Chemistry and In Vitro Screening (SFB 656 Z05)

Basic data for this project

Type of projectSubproject in DFG-joint project hosted at University of Münster
Duration at the University of Münster01/07/2009 - 30/06/2017 | 2nd Funding period

Description

Project Z5 provides all tracers established for human use within the Collaborative Research Centre 656 to the projects and supports the development of all tracers for clinical applications. The main tasks of this project include the reproduction of already synthesised and established intermediate and precursor compounds that are needed in the 2nd SFB 656 funding period. Furthermore, the GMP-conform syntheses of all promising candidate tracers for first-in-man clinical applications and the central in vitro screening of all new and modified compounds for their biological activity using in vitro assays are included.

Keywordstracer
Website of the projecthttp://www.uni-muenster.de/Sfbmobil/projekte/zentrale-projekte/z5.html
Funder / funding scheme
  • DFG - Collaborative Research Centre (SFB)

Project management at the University of Münster

Breyholz, Hans-Jörg
Clinic for Nuclear Medicine
Wagner, Stefan
Clinic for Nuclear Medicine
Wiethoff genannt Riemann, Burkhard
Clinic for Nuclear Medicine

Applicants from the University of Münster

Wiethoff genannt Riemann, Burkhard
Clinic for Nuclear Medicine